Rhinitis medicamentosa – preventable disease

Rhinitis medicamentosa – preventable disease

Aim of the study – analysis of modern ideas about the pathogenesis of rhinitis medicamentosa. The authors consider the factors causing changes in inflammatory nature and leading to rhinitis medicamentosa. The comparative estimation of modern means of pharmacotherapy was made. On the basis of literat...

Full description

Bibliographic Details
Main Authors: A. I. Kryukov, A. B. Turovskiy, I. G. Kolbanova, K. M. Musayev, A. B. Karasov
Format: Article
Language:Russian
Published: Remedium Group LLC 2019-11-01
Series:Медицинский совет
Subjects:
rhinitis medicamentosa
nasal congestion
otrivin
nasal mucosa inflammation
local decongestants
Online Access:https://www.med-sovet.pro/jour/article/view/4354
id doaj-1e090b9c49d7423d984867e620cfd28e
record_format Article
spelling doaj-1e090b9c49d7423d984867e620cfd28e2021-07-28T13:29:43ZrusRemedium Group LLCМедицинский совет2079-701X2658-57902019-11-01020273010.21518/2079-701X-2019-20-27-303903Rhinitis medicamentosa – preventable diseaseA. I. Kryukov0A. B. Turovskiy1I. G. Kolbanova2K. M. Musayev3A. B. Karasov4L.I. Sverzhevsky Research Clinical Institute of Otorhinolaryngology; N.I. Pirogov Russian National Research Medical UniversityL.I. Sverzhevsky Research Clinical Institute of Otorhinolaryngology; V.V. Veresaev Municipal Clinical HospitalL.I. Sverzhevsky Research Clinical Institute of OtorhinolaryngologyL.I. Sverzhevsky Research Clinical Institute of OtorhinolaryngologyL.I. Sverzhevsky Research Clinical Institute of OtorhinolaryngologyAim of the study – analysis of modern ideas about the pathogenesis of rhinitis medicamentosa. The authors consider the factors causing changes in inflammatory nature and leading to rhinitis medicamentosa. The comparative estimation of modern means of pharmacotherapy was made. On the basis of literature and clinical research data, it is concluded that Otrivin has a much more gentle effect and contributes less to the development of rhinitis medicamentosa.https://www.med-sovet.pro/jour/article/view/4354rhinitis medicamentosanasal congestionotrivinnasal mucosa inflammationlocal decongestants
collection DOAJ
language Russian
format Article
sources DOAJ
author A. I. Kryukov
A. B. Turovskiy
I. G. Kolbanova
K. M. Musayev
A. B. Karasov
spellingShingle A. I. Kryukov
A. B. Turovskiy
I. G. Kolbanova
K. M. Musayev
A. B. Karasov
Rhinitis medicamentosa – preventable disease
Медицинский совет
rhinitis medicamentosa
nasal congestion
otrivin
nasal mucosa inflammation
local decongestants
author_facet A. I. Kryukov
A. B. Turovskiy
I. G. Kolbanova
K. M. Musayev
A. B. Karasov
author_sort A. I. Kryukov
title Rhinitis medicamentosa – preventable disease
title_short Rhinitis medicamentosa – preventable disease
title_full Rhinitis medicamentosa – preventable disease
title_fullStr Rhinitis medicamentosa – preventable disease
title_full_unstemmed Rhinitis medicamentosa – preventable disease
title_sort rhinitis medicamentosa – preventable disease
publisher Remedium Group LLC
series Медицинский совет
issn 2079-701X
2658-5790
publishDate 2019-11-01
description Aim of the study – analysis of modern ideas about the pathogenesis of rhinitis medicamentosa. The authors consider the factors causing changes in inflammatory nature and leading to rhinitis medicamentosa. The comparative estimation of modern means of pharmacotherapy was made. On the basis of literature and clinical research data, it is concluded that Otrivin has a much more gentle effect and contributes less to the development of rhinitis medicamentosa.
topic rhinitis medicamentosa
nasal congestion
otrivin
nasal mucosa inflammation
local decongestants
url https://www.med-sovet.pro/jour/article/view/4354
work_keys_str_mv AT aikryukov rhinitismedicamentosapreventabledisease
AT abturovskiy rhinitismedicamentosapreventabledisease
AT igkolbanova rhinitismedicamentosapreventabledisease
AT kmmusayev rhinitismedicamentosapreventabledisease
AT abkarasov rhinitismedicamentosapreventabledisease
_version_ 1721273673984245760

Similar Items